Lamina-associated polypeptide-1 interacts with the muscular dystrophy protein emerin and is essential for skeletal muscle maintenance

Developmental Cell

Volumn 26, Issue 6, 2013, Pages 591-603

  Shin, Ji Yeon ^a   Méndez López, Iván ^a   Wang, Yuexia ^a   Hays, ArthurP ^a   Tanji, Kurenai ^a   Lefkowitch, JayH ^a   Schulze, P Christian ^a   Worman, HowardJ ^a   Dauer, WilliamT ^b  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMERIN; LAMINA ASSOCIATED POLYPEPTIDE 1; POLYPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; EMBRYO; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIVER CELL; LIVER FUNCTION; MOUSE; MUSCLE FUNCTION; MUSCULAR DYSTROPHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PROTEIN INTERACTION; SKELETAL MUSCLE;

ANIMALS; CELLS, CULTURED; FIBROBLASTS; GENE DELETION; HEK293 CELLS; HEPATOCYTES; HUMANS; LIVER; MEMBRANE PROTEINS; MICE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, EMERY-DREIFUSS; NUCLEAR PROTEINS; PROTEIN BINDING; TNF RECEPTOR-ASSOCIATED FACTOR 3;

MUS;

EID: 84884729973     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2013.08.012     Document Type: Article

References (45)

1. Astejada M.N., Goto K., Nagano A., Ura S., Noguchi S., Nonaka I., Nishino I., Hayashi Y.K. Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan. Acta Myol. 2007, 26:159-164.
2. Beedle A.M., Turner A.J., Saito Y., Lueck J.D., Foltz S.J., Fortunato M.J., Nienaber P.M., Campbell K.P. Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy. J.Clin. Invest. 2012, 122:3330-3342.
3. Bione S., Maestrini E., Rivella S., Mancini M., Regis S., Romeo G., Toniolo D. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat. Genet. 1994, 8:323-327.
4. Bonne G., Di Barletta M.R., Varnous S., Bécane H.M., Hammouda E.H., Merlini L., Muntoni F., Greenberg C.R., Gary F., Urtizberea J.A., et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 1999, 21:285-288.
5. Brodsky G.L., Muntoni F., Miocic S., Sinagra G., Sewry C., Mestroni L. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 2000, 101:473-476.
6. Brüning J.C., Michael M.D., Winnay J.N., Hayashi T., Hörsch D., Accili D., Goodyear L.J., Kahn C.R. Mol. Cell 1998, 2:559-569.
7. Clements L., Manilal S., Love D.R., Morris G.E. Direct interaction between emerin and lamin A. Biochem. Biophys. Res. Commun. 2000, 267:709-714.
8. Dauer W.T., Worman H.J. The nuclear envelope as a signaling node in development and disease. Dev. Cell 2009, 17:626-638.
9. Deconinck A.E., Rafael J.A., Skinner J.A., Brown S.C., Potter A.C., Metzinger L., Watt D.J., Dickson J.G., Tinsley J.M., Davies K.E. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 1997, 90:717-727.
10. Dedeic Z., Cetera M., Cohen T.V., Holaska J.M. Emerin inhibits Lmo7 binding to the Pax3 and MyoD promoters and expression of myoblast proliferation genes. J.Cell Sci. 2011, 124:1691-1702.
11. Di Barletta R.M., Ricci E., Galluzzi G., Tonali P., Mora M., Morandi L., Romorini A., Voit T., Orstavik K.H., Merlini L., et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 2000, 66:1407-1412.
12. Emery A.E., Dreifuss F.E. Unusual type of benign x-linked muscular dystrophy. J.Neurol. Neurosurg. Psychiatry 1966, 29:338-342.
13. Fairley E.A., Kendrick-Jones J., Ellis J.A. The Emery-Dreifuss muscular dystrophy phenotype arises from aberrant targeting and binding of emerin at the inner nuclear membrane. J.Cell Sci. 1999, 112:2571-2582.
14. Fatkin D., MacRae C., Sasaki T., Wolff M.R., Porcu M., Frenneaux M., Atherton J., Vidaillet H.J., Spudich S., De Girolami U., et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N.Engl. J. Med. 1999, 341:1715-1724.
15. Foisner R., Gerace L. Integral membrane proteins of the nuclear envelope interact with lamins and chromosomes, and binding is modulated by mitotic phosphorylation. Cell 1993, 73:1267-1279.
16. Goodchild R.E., Dauer W.T. The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. J.Cell Biol. 2005, 168:855-862.
17. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.S., Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 1997, 90:729-738.
18. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
19. Hoffman E.P., Knudson C.M., Campbell K.P., Kunkel L.M. Subcellular fractionation of dystrophin to the triads of skeletal muscle. Nature 1987, 330:754-758.
20. Holaska J.M., Wilson K.L. An emerin "proteome": purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture. Biochemistry 2007, 46:8897-8908.
21. Huranová M., Jablonski J.A., Benda A., Hof M., Stanek D., Caputi M. Invivo detection of RNA-binding protein interactions with cognate RNA sequences by fluorescence resonance energy transfer. RNA 2009, 15:2063-2071.
22. Kim C.E., Perez A., Perkins G., Ellisman M.H., Dauer W.T. A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. Proc. Natl. Acad. Sci. USA 2010, 107:9861-9866.
23. Maison C., Pyrpasopoulou A., Theodoropoulos P.A., Georgatos S.D. The inner nuclear membrane protein LAP1 forms a native complex with B-type lamins and partitions with spindle-associated mitotic vesicles. EMBO J. 1997, 16:4839-4850.
24. Manilal S., Nguyen T.M., Sewry C.A., Morris G.E. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum. Mol. Genet. 1996, 5:801-808.
25. Melcon G., Kozlov S., Cutler D.A., Sullivan T., Hernandez L., Zhao P., Mitchell S., Nader G., Bakay M., Rottman J.N., et al. Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. Hum. Mol. Genet. 2006, 15:637-651.
26. Muchir A., Bonne G., van der Kooi A.J., van Meegen M., Baas F., Bolhuis P.A., de Visser M., Schwartz K. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum. Mol. Genet. 2000, 9:1453-1459.
27. Muchir A., Reilly S.A., Wu W., Iwata S., Homma S., Bonne G., Worman H.J. Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene. Cardiovasc. Res. 2012, 93:311-319.
28. Nagano A., Koga R., Ogawa M., Kurano Y., Kawada J., Okada R., Hayashi Y.K., Tsukahara T., Arahata K. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nat. Genet. 1996, 12:254-259.
29. Östlund C., Ellenberg J., Hallberg E., Lippincott-Schwartz J., Worman H.J. Intracellular trafficking of emerin, the Emery-Dreifuss muscular dystrophy protein. J.Cell Sci. 1999, 112:1709-1719.
30. Östlund C., Sullivan T., Stewart C.L., Worman H.J. Dependence of diffusional mobility of integral inner nuclear membrane proteins on A-type lamins. Biochemistry 2006, 45:1374-1382.
31. Östlund C., Folker E.S., Choi J.C., Gomes E.R., Gundersen G.G., Worman H.J. Dynamics and molecular interactions of linker of nucleoskeleton and cytoskeleton (LINC) complex proteins. J.Cell Sci. 2009, 122:4099-4108.
32. Ozawa R., Hayashi Y.K., Ogawa M., Kurokawa R., Matsumoto H., Noguchi S., Nonaka I., Nishino I. Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles. Am. J. Pathol. 2006, 168:907-917.
33. Pan D., Estevez-Salmeron L.D., Stroschein S.L., Zhu X., He J., Zhou S., Luo K. The integral inner nuclear membrane protein MAN1 physically interacts with the R-Smad proteins to repress signaling by the transforming growth factor-β superfamily of cytokines. J.Biol. Chem. 2005, 280:15992-16001.
34. Pedemonte M., Sandri C., Schiaffino S., Minetti C. Early decrease of IIx myosin heavy chain transcripts in Duchenne muscular dystrophy. Biochem. Biophys. Res. Commun. 1999, 255:466-469.
35. Periasamy A., Wallrabe H., Chen Y., Barroso M. Chapter 22: Quantitation of protein-protein interactions: confocal FRET microscopy. Methods Cell Biol. 2008, 89:569-598.
36. Postic C., Shiota M., Niswender K.D., Jetton T.L., Chen Y., Moates J.M., Shelton K.D., Lindner J., Cherrington A.D., Magnuson M.A. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J.Biol. Chem. 1999, 274:305-315.
37. Raharjo W.H., Enarson P., Sullivan T., Stewart C.L., Burke B. Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy. J.Cell Sci. 2001, 114:4447-4457.
38. Roux K.J., Burke B. Nuclear envelope defects in muscular dystrophy. Biochim. Biophys. Acta 2007, 1772:118-127.
39. Semenova E., Wang X., Jablonski M.M., Levorse J., Tilghman S.M. An engineered 800 kilobase deletion of Uchl3 and Lmo7 on mouse chromosome 14 causes defects in viability, postnatal growth and degeneration of muscle and retina. Hum. Mol. Genet. 2003, 12:1301-1312.
40. Senior A., Gerace L. Integral membrane proteins specific to the inner nuclear membrane and associated with the nuclear lamina. J.Cell Biol. 1988, 107:2029-2036.
41. Spurney C.F., Gordish-Dressman H., Guerron A.D., Sali A., Pandey G.S., Rawat R., Van Der Meulen J.H., Cha H.J., Pistilli E.E., Partridge T.A., et al. Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve 2009, 39:591-602.
42. Sullivan T., Escalante-Alcalde D., Bhatt H., Anver M., Bhat N., Nagashima K., Stewart C.L., Burke B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J.Cell Biol. 1999, 147:913-920.
43. Webster C., Silberstein L., Hays A.P., Blau H.M. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 1988, 52:503-513.
44. Wilson K.L., Foisner R. Lamin-binding proteins. Cold Spring Harb. Perspect. Biol. 2010, 2:a000554.
45. Yates J.R., Wehnert M. The Emery-Dreifuss Muscular Dystrophy Mutation Database. Neuromuscul. Disord. 1999, 9:199.